Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Mallinckrodt
Cerilliant
Healthtrust
McKinsey
Cantor Fitzgerald
Harvard Business School
Merck
Citi
Accenture

Generated: August 17, 2017

DrugPatentWatch Database Preview

Recordati Rare Company Profile

« Back to Dashboard

What is the competitive landscape for RECORDATI RARE, and what generic alternatives to RECORDATI RARE drugs are available?

RECORDATI RARE has eight approved drugs.

There are three US patents protecting RECORDATI RARE drugs.

There are twelve patent family members on RECORDATI RARE drugs in six countries.

Summary for Applicant: Recordati Rare

Patents:3
Tradenames:9
Ingredients:8
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-007Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Recordati Rare
DESOXYN
methamphetamine hydrochloride
TABLET;ORAL005378-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
CHEMET
succimer
CAPSULE;ORAL019998-002Jan 30, 1991RXYesYes► Subscribe► Subscribe► Subscribe
Recordati Rare
COSMEGEN
dactinomycin
INJECTABLE;INJECTION050682-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Recordati Rare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-008Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for RECORDATI RARE drugs

Drugname Dosage Strength Tradename Submissiondate
ibuprofen lysine
Injection10 mg/mL, 2 mL vial
NEOPROFEN
10/1/2010

International Patent Family for Recordati Rare Drugs

Country Document Number Estimated Expiration
Austria293444► Subscribe
Germany60110185► Subscribe
Japan2002193799► Subscribe
MexicoPA02003033► Subscribe
MexicoPA01011629► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Express Scripts
Colorcon
Dow
Covington
Mallinckrodt
Baxter
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot